eEF2K Activity Determines Synergy to Cotreatment of Cancer Cells With PI3K and MEK Inhibitors. (2022)
Attributed to:
Systematic classification of phosphorylation sites for an integrative analysis of kinase signalling
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.mcpro.2022.100240
PubMed Identifier: 35513296
Publication URI: http://europepmc.org/abstract/MED/35513296
Type: Journal Article/Review
Volume: 21
Parent Publication: Molecular & cellular proteomics : MCP
Issue: 6
ISSN: 1535-9476